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ABSTRACT
Coronavirus disease 2019 (COVID-19) is a respiratory system disease that results in flu-like symptoms. It is caused by severe acute respiratory 
syndrome coronavirus 2 (SARS-COV-2) which was initially transmitted from either sea animals, wild animals like bats, or pet animals like dogs, and 
cats to humans. Since the occurrence of the first human COVID-19 case in China in 2019, the disease uses a trans-human transmission pathway. Its 
pathogenesis is almost similar to other respiratory diseases.
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INTRODUCTION
Coronavirus is the already known virus on the globe. It is believed to 
exist on the globe for many years back. It existed in different forms 
and different species of animals as well as in the external environment. 
Some of the forms of this virus have existed since its occurrence in the 
universe while others were emerged after a time, from the previous 
forms in different ways. Both the original forms, as well as the emerged 
forms of coronavirus, have varying degrees of pathogenicity. Some of 
these different forms of the virus could pass from one species of animal 
(their primary host) to other susceptible species of animals. Examples 
of the known zoonotic coronavirus forms are severe acute respiratory 
syndrome (SARS) corona and Middle-East respiratory syndrome 
(MERS) corona that could infect human beings passing from animals. 
Both SARS corona and MERS coronavirus diseases were the major 
challenges of mankind at a different time in history [1].
Human beings have tried to investigate the root cause of every 
disease that has happened at a different time in their history in this 
Universe. Science may not have proof of specific causes of some human 
challenges. In this case, what is done is logically guessing the occurrence 
using probabilities and predictions. By the same talking, for the very 
source of the current coronavirus disease 2019 (COVID-19) outbreak, 
what science has brought is guessing. This disease is widely taught 
to originate from animals. The consumption of aquatic animals, wild 
animals (bats), or domestic animals such as dogs and cats which are 
not usually known as animals for human consumption were believed 
to be a primary source of the current pandemic disease, COVID-19. 
This was the case in China which was the very first spot for the disease 
to occur in the human. Whether there existed another transmission 
mechanism of this disease from animals to humans, in addition to the 
consumption of animal products, was not yet validated. What is known 
at present is that once the disease steps its foot in humans from its 
source in animals, it freely moves across the human population of the 
globe [2].
TRANSMISSION
Even though there is a debate on the primary source of COVID-19 for 
the first human case, now the source for the succeeding human cases 
is known. These sources could be either the previously infected human 
or a contaminated environment, particularly materials contaminated 
by human’s infective droplets. The virus in an infected human or on 
contaminated material may get access to another human through direct 
contact with infected human or contaminated materials [3].
If the infected human sneeze or coughs or just exhale at a closer distance 
(usually at a 2–2-m radius) from a susceptible human, the active virus 
droplets usually get into the respiratory system of the second person. 
Introduction of the virus through the eye could also be possible. In case 
there were no human receptors during the sneezing or coughing of the 
infected human, the discharged virus may stay on any material nearby. 
There are cases in which these secondary sources become infective to 
humans. A human may handle these contaminated materials or if it is 
a foodstuff, may eat them before being properly sterilized. Then, by 
the unsterilized hand, he may touch his eyes, nose, mouth, or ears. By 
so doing, he let the virus gain access to the internal body where it can 
multiply and then cause infection [4].
The passage of the virus from one infected human being to another 
is now the major passageway against which every control effort is 
directing. Due to this priority, studies on the passage of the virus from 
animals to humans do not get much attention. Besides the transmission 
of the virus from an infected human to another human being, there may 
be a continual passage of the virus from the primary source animals to 
human as the previous practices of consuming the suspected animals 
continues at present particularly in the source country China [5].
There is no strong evidence about the existence of reservoirs and 
reinfection cases in COVID-19. Whatever the case, it is better to 
suspect such cases and gives due attention in addition to working 
on the trans-human transmission of the virus. Among human 
transmission mechanisms by themselves should be exhaustively 
validated. Because sometimes cases in which it is difficult to trace 
how the infection could occur happened. The potential of the virus 
to be viable in different environments until it catches the human host 
and the distance it can move in the air at the time of discharge from 
an infected host and even from where it precipitates on some hard 
materials is not well known [6].
PATHOGENESIS
The pathogenesis of SARS-coronavirus 2 (COV-2) is not well identified. 
This may also potentiate the rapid passage of the virus among the human 
population of the globe. Because, not knowing the pathogenesis of a 
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disease could hinder its early and effective control. The virus has different 
routes of entry to humans. The identified routes of entry include nasal, 
oral, conjunctival, and through the ears. Either direct passage from an 
infected source or hand-induced source could be the main source of the 
virus for these routes of entry. A hand is a major tool for the passage of 
this virus from an infected source to others. Due to this, one’s own hands 
become a danger and a fear, as equal as an infected person [7].
Once the SARS-COV-2 gains access to an internal body of humans through 
either of the above routes, it usually prefers to dwell in the respiratory 
systems. The respiratory system is the predilection site for this virus. The 
virus could affect humans and can result in death when it binds to any 
part of the respiratory system. Binding to and multiplying in the cells of 
the respiratory system, the virus interferes with the normal breathing 
system of the host. Difficult breathing and hypoxia are the primary cause 
of death to COVID-19. Besides, the SARS-COV-2 is an immunosuppressant 
that decreases the immunity (resistance) of an individual to any pathogen 
just like any other virus. Then the reduced immunity could further liable 
an individual to other disease complications [8].
The incubation period of the SARS-COV-2 virus ranges from 2 days 
to 2 weeks. The incubation period varies depending on the immune 
status of the host, age of an infected individual, presence or absence 
of other health complications, physiological state of female individuals, 
and a dose and route of entry of the virus. In some cases, the disease is 
symptomless while in others it is clinical which is manifested by flu-like 
symptoms. There is no pathognomonic sign for COVID-19. An infected 
individual under any one of the above disease states could shade an 
infective virus and become a danger to pass the disease to others [9].
If the person caught by SARS-COV-2 has already got other health 
complications such as heart problems, diabetes, kidney problem, and 
other respiratory problems such as asthma and any inflammation to 
respiratory parts and/or respiratory failure due to smoking, the case 
could be much aggravated. There is no evidence of whether the SARS-
COV-2 enters the body through other routes than the natural opening 
of the body. Still, there is no evidence whether the SARS-COV-2 could 
result in death due to its multiplication in other organ systems in 
addition to death due to respiratory complications [10].
CONCLUSION AND RECOMMENDATION
A lot is left to be investigated about the transmission mechanism of 
SARS-COV-2 from their very source in any of the life forms or abiotic 
environments to humans. Besides, the pathogenesis of this virus needs 
to be further investigated whether any other organ system is involved 
and could equally be responsible for the human deaths to COVID-19 as 
of the respiratory system.
In the meantime, intensively applying control mechanisms to decrease 
the passage of COVID-19 among the human population by interrupting 
the transmission pathways is mandatory. It is recommended to apply 
containment measures by limiting the virus within the infected 
individuals using methods such as isolating infected individuals by 
a strict quarantine system, using face masks, gloves, and protective 
clothes, or at least covering the nose and mouth at sneezing or coughing 
by an elbow. The last recommended control measures to be taken are 
protecting the uninfected but exposed individuals by avoiding contact 
with infected individuals by letting them stay at home, or if not possible 
to stay home, keeping at least a 2-m distance from any other individuals. 
The use of face masks, washing hands after every handling of potential 
virus source and avoiding touching nose, mouth, eye, and ear by hand 
before washing are all recommended practices to be followed to control 
the COVID-19 pandemic.
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